Lundbeck establishes a sponsored Level I ADR programme in the US
24 May 2012 | By H. Lundbeck A/S
H. Lundbeck A/S announced that the company has established a sponsored Level I ADR programme in the United States...
List view / Grid view
News
Innovative public-private collaboration launches to tackle antibiotic research
24 May 2012 | By AstraZeneca
New €224m funding to enable development of antibiotics for bacterial infections and drive unprecedented information sharing...
Pfizer names Olivier Brandicourt as President and General Manager, emerging markets and established products business units
23 May 2012 | By Pfizer
Olivier will succeed David Simmons...
€100,000 in reward donations for projects fundraising to prevent atrial fibrillation-related strokes
23 May 2012 | By Boehringer Ingelheim
1 Mission 1 Million announces its plans to support ongoing work in atrial fibrillation...
Boehringer Ingelheim announces positive phase II results for once-daily tiotropium in asthma
22 May 2012 | By Boehringer Ingelheim
Comprehensive Phase III UniTinA-asthma™ program ongoing...
View and listen to webcast of June 3 Pfizer analyst and investor meeting at ASCO
22 May 2012 | By Pfizer
View webcast of a presentation by Pfizer’s oncology leadership team...
Gerresheimer presents innovative Packaging concepts for the Latin and South American Pharma market
22 May 2012 | By Gerresheimer
Gerresheimer to present its entire portfolio of plastic pharmaceutical packaging products...
One million signatures needed to call upon WHO to save lives through education & improved management of AF
22 May 2012 | By Boehringer Ingelheim
1 Mission 1 Million launches petition and unique fundraising platform...
Daiichi Sankyo and the National Cancer Center form comprehensive research alliance
22 May 2012 | By Daiichi Sankyo
This agreement is designed to integrate the high-level cancer research technology...
Lilly Diabetes presents Phase II blood pressure and heart rate data
22 May 2012 | By Eli Lilly and Company
Phase II trial used ambulatory blood pressure monitoring to evaluate blood pressure and heart rate for dulaglutide...
Boehringer Ingelheim’s once-daily bronchodilator olodaterol* successfully completes Phase II clinical trial program in COPD
21 May 2012 | By Boehringer Ingelheim
Olodaterol significantly improved lung function (FEV 1) for at least 24 hours compared to placebo...
Fast plasma sample cleanup with new Phree Phospholipid Removal Plates
21 May 2012 | By Phenomenex Inc
Phenomenex Inc., introduces Phree Phospholipid Removal Plates for fast cleanup of plasma samples...
FDA approves new labeling for ISENTRESS® (raltegravir)
21 May 2012 | By Merck
The U.S. FDA approved a labeling update for ISENTRESS® Film-coated Tablets to include 156-week data from the STARTMRK study...
Capital increase in Lundbeck as a result of employee warrant programme
21 May 2012 | By H. Lundbeck A/S
Lundbeck increases its share capital by 593 shares as a result of employee warrant exercise...
Two overall winners announced at prestigious national award ceremony in London’s Science Museum
18 May 2012 | By GlaxoSmithKline
Judges of the GSK IMPACT Awards could not choose one overall winner for the awards...
